scholarly journals То the results of radiation and hygienic passport system of the Zelenodolsk Region territory of Tatarstan Republic in 1999

2001 ◽  
Vol 82 (4) ◽  
pp. 304-308
Author(s):  
R. M. Shigapov ◽  
V. G. Morozov ◽  
R. K. Ismagilov ◽  
V. F. Chuprun
Keyword(s):  
Effective Dose ◽  
Natural Factors ◽  
System Data ◽  
Average Individual

The average individual effective irradiation doses of population of the Zelenodolsk region by the radiation and hygienic passport system data for 1999 are determined. It is shown that 74% of the effective dose are defined by the natural factors. The measures directed to the decrease of the dose loads at the expense of medical roentgen procedures are considered. It is established that the true decrease of dose loads on population can achieved at the expense of reducing the medical irradiation part.

scholarly journals Assessment of the doses to the population of the regions of Russia from exposure to the cosmic radiation

2019 ◽  
Vol 12 (3) ◽  
pp. 78-83
Author(s):  
D. V. Kononenko ◽  
T. A. Kormanovskaya
Keyword(s):  
Effective Dose ◽  
Cosmic Radiation ◽  
Annual Effective Dose ◽  
Weighted Average ◽  
Dose Calculation ◽  
Average Value ◽  
Effective Doses ◽  
Refined Calculation ◽  
Average Individual ◽  
Regions Of Russia

The paper presents the results of a refined calculation of the average individual annual effective doses to the population of the regions of Russia from exposure to the cosmic radiation. The population-weighted average values of the altitude and latitude of the main settlements, which are home to at least 50 percent of the population of the region, were used as the altitude and latitude of the region. In addition, all settlements with a population of at least 20 thousand people were included in the calculation. Coverage of the population of the regions of Russia in the calculation varies from 50.1 to 95.8 percent (excluding three cities of Federal importance with 100 percent coverage) with the average value of 62.4 percent. The number of settlements included in the calculation in different regions ranges from 1 to 63. The methodology of the dose calculation is based on the approach described in the UNSCEAR 2000 Report. The obtained dose values for different regions range from 0.310 to 0.413 mSv. For Russia as a whole country, the population-weighted average individual annual effective dose from exposure to the cosmic radiation is 0.338 mSv.

scholarly journals Radiation doses to the population of the Russian Federation in 2020

2021 ◽  
Vol 14 (4) ◽  
pp. 103-113
Author(s):  
A. N. Barkovsky ◽  
Ruslan R. Akhmatdinov ◽  
Rustam R. Akhmatdinov ◽  
N. К. Baryshkov ◽  
A. M. Biblin ◽  
...  
Keyword(s):  
Effective Dose ◽  
Russian Federation ◽  
Annual Effective Dose ◽  
Dose Limit ◽  
The Public ◽  
Dose Control ◽  
Group A ◽  
The Russian Federation ◽  
Group B ◽  
Average Individual

The article presents estimates of radiation doses of technogenic exposure to personnel and the public due to the normal operation of radiation facilities, exposure to the public due to natural sources and technogenically altered radiation environment, and medical exposure of patients. The doses values were obtained using the Unified System of Individual Dose Control of the Russian Federation citizens for 2020. The authors have analyzed the data contained in the forms of state statistical observation No. 1-DOZ, No. 2-DOZ, No. 3-DOZ and No. 4-DOZ for 2020 submitted by the organizations and territories, the state sanitary and epidemiological supervision of which was carried out by Rospotrebnadzor and Federal Medical Biological Agency of Russia. In the article also were used data obtained within the framework of Radiation-Hygiene Passportization. In 2020, 19 737 organizations dealing with technogenic sources of ionizing radiation submitted forms No. 1-DOZ with the information on the doses to personnel with a total number of 230 318 persons, of which 230 318 persons belonged to the personnel group A and 21 303 persons belonged to the personnel group B. For these groups, the doses were assessed based on results of individual dosimetric control. In 2020, according to Unified System of Individual Dose Control of the Russian Federation citizens data, the average individual annual effective dose of technogenic exposure to the personnel group A was 1.11 mSv, and for the personnel group B it was 0.63 mSv. In 2020, 6 cases of exceeding the average annual effective dose limit (20 mSv) for Group A personnel and 18 cases of exceeding the average annual effective dose limit (5 mSv) for Group B personnel were registered. The total number of X-ray and radiological diagnostic procedures performed in the Russian Federation in 2020 exceeded 275.4 million, or 1.83 procedures per a citizen. The average annual effective dose of medical radiation exposure per one resident of Russia in 2020 was 0.81 mSv, and per procedure – 0.44 mSv. The average annual effective dose of radiation to residents of the Russian Federation from natural sources, according to all measurements for the period from 2001 to 2020, was 3.36 mSv. More than 59% of this dose is associated with the inhalation of radon and its progenies. The average individual annual effective radiation dose to residents the Russian Federation subjects in 2020 ranged from 2.47 mSv (Kamchatka Krai) to 9.06 mSv (Altai Republic) with an average value for the Russian Federation of 4.18 mSv. For eight subjects of the Russian Federation, the average individual annual effective dose to public in 2020 exceeded 5 mSv: the Republics of Buryatia (5.31 mSv), Altai (9.06 mSv), Tyva (6.31 mSv), Magadan (5.07 mSv) and Irkutsk (6.13 mSv) regions, Stavropol (6.31 mSv) and Zabaykalsky (8.19 mSv) krai and the Evreiskaya Autonomous oblast (6.77 mSv).

Radiation exposure of patients undergoing nuclear medicine procedures in Germany between 1996 and 2000

2005 ◽  
Vol 44 (05) ◽  
pp. 119-130 ◽  
Author(s):  
P. Schnell-Inderst ◽  
D. Noßke ◽  
M. Weiss ◽  
A. Stamm-Meyer ◽  
G. Brix ◽  
...  
Keyword(s):  
Nuclear Medicine ◽  
Cardiovascular System ◽  
Effective Dose ◽  
Current Status ◽  
Annual Number ◽  
Statistical Parameters ◽  
Public Health Information ◽  
Nuclear Medicine Procedures ◽  
And Gender ◽  
Icrp Publication

Summary:The aim of this study was to estimate both the frequency and effective dose of nuclear medicine procedures performed in Germany between 1996 and 2000 for different subgroups of patients. Methods: Electronically archived data from 14 hospitals and 10 private practices were restored and statistically analyzed. The effective dose per examination was calculated according to ICRP publication 80 using the tissue weighting factors given in ICRP publication 60. Based on the data collected, statistical parameters were computed to characterize the frequency and effective dose of the various nuclear medicine procedures. Results: In total, 604,771 nuclear medicine procedures performed in 433,709 patients were analyzed. On average, 1.4 examinations were carried out per patient and year. The median effective dose was 1.7 [5.-95. percentile; mean: 0.4–8.5; 2.9] mSv per examination and 2.3 [0.5–11.2; 3.5] mSv per patient. Interestingly, the mean effective dose per examination, but not the number of examinations per year increased with the age of the patients. Most frequent were examinations of the thyroid (36.7%), the skeleton (27.1%) and the cardiovascular system (11.1%), which were associated with a median effective dose of 0.5 [0.5–1.1; 0.7] mSv, 3.4 [2.9–5.1; 3.6] mSv and 7.3 [3.2–21.0; 9.5] mSv, respectively. Over the five-year period examined, the total annual number of PET procedures (222.3%) as well as of examinations of thyroid (24.5%), skeleton (17.9%), and the cardiovascular system (14.9%) increased markedly, whereas a decrease was observed for brain (-39.3%), lung (-20.2%) and renal (-15.0%) scans. Conclusion: The age- and gender-specific data presented in this study provide detailed public health information on both the current status and recent trends in the practice of diagnostic nuclear medicine examinations.

Sentinel lymph node diagnostic in prostate carcinoma: Part II: Biokinetics and dosimetry of 99mTc-Nanocolloid after intraprostatic injection

2002 ◽  
Vol 41 (02) ◽  
pp. 102-107 ◽  
Author(s):  
J. Kopp ◽  
H. Vogt ◽  
F. Wawroschek ◽  
S. Gröber ◽  
R. Dorn ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Lymph Node ◽  
Urinary Bladder ◽  
Lymph Nodes ◽  
Effective Dose ◽  
Residual Activity ◽  
Tracer Uptake ◽  
Lymphatic Transport ◽  
Radionuclide Distribution ◽  
Radioactivity Uptake

Summary Aim: To visualise the sentinel lymph nodes (SLNs) of the prostate we injected the radiotracer into the parenchyma of the prostate. The activity was deposited in liver, spleen, bone marrow, urinary bladder and regional lymphatic system. The aim of this work is to determine biokinetical data and to estimate radiation doses to the patient. Methods: The patients with prostate cancer received a sonographically controlled, transrectal administration of 99mTc-Nanocoll®, injected directly into both prostate lobes. In 10 randomly selected patients radionuclide distribution and its time course was determined via regions of interest (ROIs) over prostate, urinary bladder, liver, spleen and the lymph nodes. The uptake in the SLNs was estimated from gamma probe measurements at the surgically removed nodes. To compare tumour positive with tumour free lymph nodes according to SLN-uptake and SLNlocalisation we evaluated 108 lymph nodes out of 24 patients with tumour positive SLN. For calculating the effective dose according to ICRP 60 of the patients we used the MIRD-method and the Mirdose 3.1 software. Results: The average uptake of separate organs was: bladder content 24%, liver 25.5%, spleen 2%, sum of SLN 0.5%. An average of 9% of the applied activity remained in the prostate. The residual activity was mainly accumulated in bone marrow and blood. Occasionally a weak activity enrichment in intestinal tract and kidneys could be recognized. The effective dose to the patient was estimated to 7.6 μSv/MBq. The radioactivity uptake of the SLN varied in several orders of magnitude between 0.006% and 0.6%. The probability of SLN-metastasis was found to be independent from tracer uptake in the lymph node. The radioactivity uptake of the SLNs in distinct lymph node regions showed no significant differences. Conclusion: The radiotracer is transferred out of the prostate via blood flow, by direct transfer via the urethra into the bladder and by lymphatic transport. Injecting a total activity of 200 MBq leads to a mean effective dose of 1.5 mSv. It is not recommended to use the tracer uptake in lymph nodes as the only criterion to characterize SLNs.

A Comparative Ex Vivo Study of Plasminogen Activators and Proteases for Fibrinolytic Activity and Side Effects in Rabbits

1977 ◽  
Vol 37 (01) ◽  
pp. 154-161 ◽  
Author(s):  
B. A Janik ◽  
S. E Papaioannou
Keyword(s):  
Side Effects ◽  
Effective Dose ◽  
Fibrinolytic Activity ◽  
Ex Vivo ◽  
Plasminogen Activators ◽  
Assay System ◽  
Coagulation Parameters ◽  
Ex Vivo Assay

SummaryUrokinase, streptokinase, Brinase, trypsin, and SN 687, a bacterial exoprotease, have been evaluated in an ex vivo assay system. These enzymes were injected into rabbits and the fibrinolytic activity as well as other coagulation parameters were measured by in vitro techniques. Dose-response correlations have been made using the euglobulin lysis time as a measure of fibrinolytic activity and the 50% effective dose has been determined for each enzyme. Loading doses, equal to four times the 50% effective dose, were administered to monitor potential toxicity revealing that Brinase, trypsin, and SN 687 were very toxic at this concentration.Having established the 50% effective dose for each enzyme, further testing was conducted where relevant fibrinolytic and coagulation parameters were measured for up to two days following a 50% effective dose bolus injection of each enzyme. Our results have demonstrated that urokinase and streptokinase are plasminogen activators specifically activating the rabbit fibrinolytic system while Brinase, trypsin and SN 687 increase the general proteolytic activity in vivo.The advantages of this ex vivo assay system for evaluating relative fibrinolytic potencies and side effects for plasminogen activators and fibrinolytic proteases have been discussed.

Predicting Daily Maintenance Dose of Fluindione, an Oral Anticoagulant Drug

1996 ◽  
Vol 75 (05) ◽  
pp. 731-733 ◽  
Author(s):  
V Cazaux ◽  
B Gauthier ◽  
A Elias ◽  
D Lefebvre ◽  
J Tredez ◽  
...  
Keyword(s):  
Effective Dose ◽  
Maintenance Dose ◽  
Successive Approximations ◽  
Hemorrhagic Complication ◽  
Simple Method ◽  
Individual Variations ◽  
Anticoagulant Drug ◽  
The Mean ◽  
Mean Time ◽  
Daily Maintenance Dose

SummaryDue to large inter-individual variations, the dose of vitamin K antagonist required to target the desired hypocoagulability is hardly predictible for a given patient, and the time needed to reach therapeutic equilibrium may be excessively long. This work reports on a simple method for predicting the daily maintenance dose of fluindione after the third intake. In a first step, 37 patients were delivered 20 mg of fluindione once a day, at 6 p.m. for 3 consecutive days. On the morning of the 4th day an INR was performed. During the following days the dose was adjusted to target an INR between 2 and 3. There was a good correlation (r = 0.83, p<0.001) between the INR performed on the morning of day 4 and the daily maintenance dose determined later by successive approximations. This allowed us to write a decisional algorithm to predict the effective maintenance dose of fluindione from the INR performed on day 4. The usefulness and the safety of this approach was tested in a second prospective study on 46 patients receiving fluindione according to the same initial scheme. The predicted dose was compared to the effective dose soon after having reached the equilibrium, then 30 and 90 days after. To within 5 mg (one quarter of a tablet), the predicted dose was the effective dose in 98%, 86% and 81% of the patients at the 3 times respectively. The mean time needed to reach the therapeutic equilibrium was reduced from 13 days in the first study to 6 days in the second study. No hemorrhagic complication occurred. Thus the strategy formerly developed to predict the daily maintenance dose of warfarin from the prothrombin time ratio or the thrombotest performed 3 days after starting the treatment may also be applied to fluindione and the INR measurement.

SenCity – Evaluating Users’ Experiences of Intelligent Lighting for Well-Being in Smart Cities

2018 ◽  
pp. 60-67
Author(s):  
Henrika Pihlajaniemi ◽  
Anna Luusua ◽  
Eveliina Juntunen
Keyword(s):  
Case Studies ◽  
Smart City ◽  
Smart Cities ◽  
Well Being ◽  
Evaluation Methods ◽  
Data Analyses ◽  
Sense Of Security ◽  
System Data

This paper presents the evaluation of usersХ experiences in three intelligent lighting pilots in Finland. Two of the case studies are related to the use of intelligent lighting in different kinds of traffic areas, having emphasis on aspects of visibility, traffic and movement safety, and sense of security. The last case study presents a more complex view to the experience of intelligent lighting in smart city contexts. The evaluation methods, tailored to each pilot context, include questionnaires, an urban dashboard, in-situ interviews and observations, evaluation probes, and system data analyses. The applicability of the selected and tested methods is discussed reflecting the process and achieved results.

IoT based e-Healthcare System to Enable Remote Patient Care based on Cloud Server

2017 ◽  
Vol 7 (7) ◽  
pp. 36
Author(s):  
P.Venu Gopala Rao ◽  
Eslavath Raja ◽  
Ramakrishna Gandi ◽  
G. Ravi Kumar
Keyword(s):  
Low Cost ◽  
Vital Signs ◽  
Smart Phone ◽  
Medical Professional ◽  
Design Parameters ◽  
Cloud Server ◽  
Significant Area ◽  
Efficient Data ◽  
System Data ◽  
Remote Patient

IoT (Internet of Things) has become most significant area of research to design an efficient data enabled services with the help of sensors. In this paper, a low-cost system design for e-healthcare service to process the sensitive health data is presented. Vital signs of the human body are measured from the patient location and shared with a registered medical professional for consultation. Temperature and heart rate are the major signals obtained from a patient for the initial build of the system. Data is sent to a cloud server where processing and analysis is provided for the medical professional to analyze. Secure transmission and dissemination of data through the cloud server is provided with an authentication system and the patient could be able to track his data through a smart phone on connecting to the cloud server. A prototype of the system along with its design parameters has been discussed.

Sign in / Sign up

Export Citation Format

Share Document